Cargando…
First description of atrial fibrillation and congenital thrombotic thrombocytopenic purpura treated by left atrial appendage occlusion
Given an increased risk of both thrombosis and bleeding, thrombotic thrombocytopenic purpura (TTP) presents a unique challenge when anticoagulation is required for comorbid disease, particularly in the setting of major bleeding events. We present for the first time a patient with TTP and atrial fibr...
Autores principales: | Basrawala, Hussain, Finley, Katherine, Jaglal, Michael, Mohanty, Bibhu D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188452/ https://www.ncbi.nlm.nih.gov/pubmed/37206280 http://dx.doi.org/10.1002/jha2.659 |
Ejemplares similares
-
Rudimentary left atrial appendage in atrial fibrillation, congenital occlusion device, or continued thrombotic risk
por: Dawdy, John, et al.
Publicado: (2021) -
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer
por: Shabtaie, Samuel A., et al.
Publicado: (2023) -
Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Covid-19-vaccine-pfizer-biontech: Atrial fibrillation and relapse of immune thrombotic thrombocytopenic purpura: case report
Publicado: (2022)